As Covid-19 pressures mount, political newcomer Stephen Hahn struggles to protect an FDA under siege
WASHINGTON — Stephen Hahn, a political novice who moved here in December to take over the Food and Drug Administration, has found himself steering his agency through the most tumultuous time in its history.
But with almost no institutional knowledge behind him, FDA experts worry he’s flying blind, leaving the agency flailing despite its vital role in the effort to control the spread of Covid-19.
